StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) income statement

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$79.47−2.43 (-2.97%)

Close on Nov 20, 2026Market cap $7.04BP/E –Yield –

See a number that looks wrong?